The WHO panel is also evaluating data for Pfizer’s antiviral pill, paxlovid, and a widely available antidepressant, fluvoxamine, to treat Covid-19.
WHO Backs Merck’s Antiviral Pill For High-Risk Covid Patients But Finds Regeneron’s Antibody Cocktail ‘Ineffective’ Against Omicron
